Wistar Institute leveraging Allevi bioprinting for COVID-19 research AM Industry
The Wistar Institute, a biomedical research center focused on studying cancer, immunology and infectious diseases, is collaborating with biofabrication company Allevi to explore the use of bioprinting technologies to fight COVID-19. Specifically, Allevi’s bioprinting platform will be used to 3D print lung models to study the effects of SARS-CoV-2.